InsiderClue
← All stocks

Arcutis Biotherapeutics, Inc.

ARQT Net buying
CIK 0001787306 #1713 in the set updated 17 Sep 2026
Bought (120 mo)
$71.63M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$60.70M
$16.30M on a plan · $12.65M straight out of an exercise
Sold at will
$31.74M
108 of 341 sales
Net
+$10.93M
+$39.89M against sales at will

By person

27 insiders · 400 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SILVERSTEIN JONATHAN
Director
$21.90M (4)
—
+$21.90M
902,286
0.7179%
$22.58M
—
Frazier Life Sciences VIII, L.P.
10% owner
$13.70M (3)
—
+$13.70M
8,818,574
7.02%
$220.69M
+1,465%
Watanabe Todd
See Remarks
$30.58K (3)
$9.30M (78) scheduled
−$9.27M
924,927
0.7359%
$23.15M
+70.8%
Heron Patrick J
Director
$9.07M (11)
—
+$9.07M
10,602,451
8.44%
$265.34M
+2,073%
Welgus Howard G.
Director
—
$6.55M (73) scheduled
−$6.55M
61,466
0.0489%
$1.54M
−56.1%
Burnett Patrick
See Remarks
—
$5.86M (53) scheduled
−$5.86M
117,592
0.0936%
$2.94M
—
Bain Capital Life Sciences Investors, LLC entity
10% owner
$5.00M (1)
—
+$5.00M
3,979,292
3.17%
$99.59M
—
ORBIMED ADVISORS LLC entity
10% owner
$21.90M (4)
$25.45M (8)
−$3.55M
1,317,428
1.05%
$32.97M
—
Matsuda Masaru
See Remarks
$18.54K (2)
$3.36M (35) scheduled
−$3.34M
116,182
0.0924%
$2.91M
+4,319%
CHAUDHURI BHASKAR
Director
—
$1.83M (12)
−$1.83M
917,807
0.7302%
$22.97M
+6.2%
Edwards Larry Todd
See Remarks
$7.77K (1)
$1.21M (10)
−$1.20M
175,178
0.1394%
$4.38M
+11,998%
OSBORNE DAVID W
Chief Technical Officer
—
$1.10M (12)
−$1.10M
331,332
0.2636%
$8.29M
+10.8%
Curran Terrie
Director
—
$1.08M (4) scheduled
−$1.08M
23,526
0.0187%
$588.76K
—
Leonard Keith R
Director
—
$997.19K (1) scheduled
−$997.19K
27,901
0.0222%
$698.25K
—
Krishnamohan Neha
Director
—
$939.49K (2) scheduled
−$939.49K
27,901
0.0222%
$698.25K
+2,165%
LIN SUE-JEAN
Director
—
$898.54K (2) scheduled
−$898.54K
27,567
0.0219%
$689.89K
+9,089%
Smither John W
Chief Financial Officer
—
$619.52K (13) scheduled
−$619.52K
98,080
0.0780%
$2.45M
+78.4%
Gilbert Halley E
Director
—
$455.44K (1) scheduled
−$455.44K
27,901
0.0222%
$698.25K
—
Burrows Scott L
Chief Financial Officer
—
$298.56K (8)
−$298.56K
59,115
0.0470%
$1.48M
+67.8%
Topper David Joseph
Chief Financial Officer
—
$261.96K (2) scheduled
−$261.96K
182,774
0.1454%
$4.57M
—
Vairavan Latha
SVP Chief Financial Officer
—
$149.77K (7) scheduled
−$149.77K
85,978
0.0684%
$2.15M
+90.6%
Turney Patricia A.
SVP, Operations
—
$116.57K (8)
−$116.57K
62,862
0.0500%
$1.57M
—
Lock Kenneth A.
Chief Commercial Officer
—
$116.22K (8)
−$116.22K
63,429
0.0505%
$1.59M
+1,545%
Moore Matthew Richard
SVP and Chief Business Officer
—
$104.95K (4) scheduled
−$104.95K
145,505
0.1158%
$3.64M
—
Munshi Amit
Director
—
—
—
9,799
0.0078%
$245.23K
+390.0%
Peetz Christopher
Director
—
—
—
4,315
0.0034%
$107.99K
—
TURNER JOSEPH L
Director
—
—
—
4,312
0.0034%
$107.91K
—

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Curran Terrie
27 Aug 2026
Director
Sold after exercise
27,052
$25.03
$677.10K
Curran Terrie
27 Aug 2026
Director
Sold after exercise
11,148
$25.03
$279.03K
Curran Terrie
20 Aug 2026
Director
Sold after exercise
1,072
$26.04
$27.91K
Welgus Howard G.
17 Aug 2026
Director
Sold after exercise
4,730
$26.18
$123.83K
Burnett Patrick
12 Aug 2026
See Remarks
Sold after exercise
6,700
$26.08
$174.77K
Burnett Patrick
11 Aug 2026
See Remarks
Sold after exercise
8,300
$26.52
$220.13K
Welgus Howard G.
15 Jul 2026
Director
Sold after exercise
4,730
$26.91
$127.28K
Welgus Howard G.
15 Jun 2026
Director
Sold after exercise
4,096
$24.41
$99.98K
Leonard Keith R
2 Mar 2026
Director
Sold after exercise
39,272
$25.39
$997.19K
Burnett Patrick
15 Dec 2025
See Remarks
Sold after exercise
11,500
$28.94
$332.85K
LIN SUE-JEAN
24 Nov 2025
Director
Sold after exercise
25,272
$30.78
$777.96K
Gilbert Halley E
20 Nov 2025
Director
Sold after exercise
16,532
$27.55
$455.44K
Krishnamohan Neha
13 Nov 2025
Director
Sold after exercise
1,232
$23.37
$28.79K
Krishnamohan Neha
13 Nov 2025
Director
Sold after exercise
39,272
$23.19
$910.70K
Burnett Patrick
6 Nov 2025
See Remarks
Sold after exercise
17,250
$24.18
$417.14K
Welgus Howard G.
1 Oct 2025
Director
Sold after exercise
462
$18.92
$8.74K
Welgus Howard G.
1 Oct 2025
Director
Sold after exercise
9,538
$18.92
$180.48K
Welgus Howard G.
2 Sep 2025
Director
Sold after exercise
10,000
$15.64
$156.38K
Welgus Howard G.
1 Aug 2025
Director
Sold after exercise
3,890
$14.30
$55.62K
Welgus Howard G.
1 Aug 2025
Director
Sold after exercise
6,110
$14.30
$87.36K
Burnett Patrick
14 Jul 2025
See Remarks
Sold after exercise
5,750
$15.07
$86.65K
Burnett Patrick
10 Jul 2025
See Remarks
Sold after exercise
23,000
$15.05
$346.05K
Burnett Patrick
14 Mar 2025
See Remarks
Sold after exercise
12,242
$15.04
$184.11K
Burnett Patrick
13 Mar 2025
See Remarks
Sold after exercise
5,008
$15.10
$75.63K
Burnett Patrick
13 Mar 2025
See Remarks
Sold after exercise
44,153
$14.97
$660.77K
Burnett Patrick
22 Nov 2024
See Remarks
Sold after exercise
16,023
$10.14
$162.51K
Burnett Patrick
15 Nov 2024
See Remarks
Sold after exercise
100
$10.03
$1.00K
Burnett Patrick
14 Nov 2024
See Remarks
Sold after exercise
18,377
$10.29
$189.18K
Burnett Patrick
14 Nov 2024
See Remarks
Sold after exercise
50,749
$10.29
$522.44K
Welgus Howard G.
1 Aug 2024
Director
Sold after exercise
3,386
$9.87
$33.42K
Welgus Howard G.
1 Aug 2024
Director
Sold after exercise
6,614
$9.87
$65.28K
Welgus Howard G.
1 Jul 2024
Director
Sold after exercise
10,000
$9.31
$93.14K
Welgus Howard G.
4 Jun 2024
Director
Sold after exercise
6,458
$8.01
$51.76K
Welgus Howard G.
4 Jun 2024
Director
Sold after exercise
3,542
$8.00
$28.34K
Burnett Patrick
30 May 2024
See Remarks
Sold after exercise
23,000
$8.75
$201.32K
Welgus Howard G.
17 Apr 2023
Director
Sold after exercise
8,500
$13.97
$118.73K
Welgus Howard G.
6 Apr 2023
Director
Sold after exercise
8,500
$12.01
$102.09K
Welgus Howard G.
15 Feb 2023
Director
Sold after exercise
8,500
$16.98
$144.35K
Welgus Howard G.
17 Jan 2023
Director
Sold after exercise
8,500
$13.72
$116.65K
Welgus Howard G.
15 Nov 2022
Director
Sold after exercise
3,403
$20.01
$68.10K
Watanabe Todd
5 Aug 2022
President and CEO
Sold after exercise
2,500
$24.74
$61.86K
Watanabe Todd
8 Jul 2022
President and CEO
Sold after exercise
7,087
$25.41
$180.11K
Watanabe Todd
8 Jul 2022
President and CEO
Sold after exercise
4,913
$25.41
$124.86K
Watanabe Todd
8 Jul 2022
President and CEO
Sold after exercise
1,500
$25.00
$37.50K
Welgus Howard G.
1 Jun 2022
Director
Sold after exercise
2,500
$20.62
$51.54K
Welgus Howard G.
2 May 2022
Director
Sold after exercise
2,500
$20.44
$51.11K
Showing 250 of 400 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 390
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 124
Sales straight out of an exercise 109
Sales at will 108
Transactions with no price 0
Shares from compensation/vesting 37,239,743
Sales filed before the plan box existed 97
History held since 3 Feb 2020